Multicentric Study to evaluate the effectiveness of ThermalytixÂ© (automated thermographic screening algorithms developed by NIRAMAI) as compared to standard screening modalities in subjects who show possible symptoms of suspected breast cancer - SANT17

IRAMAI Health Analytix Pvt Ltd0 个研究点目标入组 258 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1. Female subjects equal to and above 18 years presenting with the following breast abnormalities:
•(1a) Palpable lump, swelling or mass in breast
•(1b) Persistent breast pain or tenderness that is unrelated to menstrual cycle
•(1c) Nipple is inverted or tender, painful, scaly or with discharge (clear or bloody)
•(1d) Skin on breast is dimpled, red, blotchy, pricking, itchy or has change in the texture
•(1e) Increase in breast size that is not related to menstrual cycle
•(1f) Thickening in or around the breast or underarm area
•(1g) Or any other symptoms leading to suspicion of breast cancer
•2. Subjects who are willing to give written informed consent for study participation
•3. Subjects who are ready to comply with the study related visits and procedures

•1. Subjects who are pregnant
•2. Subjects who are lactating
•3. Subjects who have undergone either lumpectomy or mastectomy
•4. Subjects who have undergone Chemotherapy in the last 2 weeks at the time of study enrollment
•5. Any active illness, psychological and/or pathological condition that would interfere with study participation in the opinion of the Investigator

发起方

IRAMAI Health Analytix Pvt Ltd